Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ismail Azzabi Zouraq"'
Autor:
Claudio Marelli, Ismail Azzabi Zouraq, Helene Vintderdag, Kamran Iqbal, Neil Gittoes, Jay Were, Nin Dass
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d991238be00d706810e4c5c9e98803a
https://doi.org/10.1530/endoabs.73.aep93
https://doi.org/10.1530/endoabs.73.aep93
Publikováno v:
PharmacoEconomics. 35:33-41
A condition-specific preference-based measure (CSPBM) is a measure of health related quality of life (HRQoL) that is specific to a certain condition or disease and that can be used to obtain the quality adjustment weight of the quality adjusted life
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aedf682e103d9d432d49b44aadf0c2ba
https://doi.org/10.1007/s40273-017-0546-9
https://doi.org/10.1007/s40273-017-0546-9
Autor:
Ben van Hout, John Brazier, Tessa Peasgood, Helene Chevrou-Severac, Suzy Paisley, Clara Mukuria, Ismail Azzabi-Zouraq, Roberta Ara, Donna Rowen, Tracey Young
Publikováno v:
PharmacoEconomics. 35:7-9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71ba5f161b45125a2118ab80f91c0880
https://doi.org/10.1007/s40273-017-0543-z
https://doi.org/10.1007/s40273-017-0543-z
Methodological issues of how to use health state utility values (HSUVs) in decision models arise frequently, including the most appropriate evidence to use as the baseline (e.g. the baseline HSUVs associated with avoiding a particular health conditio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e0dd8f6c0e9912f3b6466025af695dc
Autor:
Ross Selby, Helene Chevrou-Severac, Michele Wilson, Matthew C. Kerrigan, Ismail Azzabi Zouraq
Publikováno v:
ClinicoEconomics and Outcomes Research: CEOR
Michele R Wilson,1 Ismail Azzabi Zouraq,2 Helene Chevrou-Severac,2 Ross Selby,3 Matthew C Kerrigan4 1RTI Health Solutions, Research Triangle Park, NC, USA; 2Takeda Pharmaceuticals International AG, Zurich, Switzerland; 3Takeda UK Ltd., Bucks, UK; 4PH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95df21e4a77434a5dc3e16e6985edf0a
https://pubmed.ncbi.nlm.nih.gov/29081667
https://pubmed.ncbi.nlm.nih.gov/29081667
Publikováno v:
PharmacoEconomics. 35(Suppl 1)
Recommendations and guidelines for the collection, generation, source and usage of utility data for health technology assessment (HTA) vary across different countries, with no international consensus. Many international agencies generate their own gu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fa3e51644452beb0eda73eee527919d
https://pubmed.ncbi.nlm.nih.gov/29052162
https://pubmed.ncbi.nlm.nih.gov/29052162